TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
EOLS

Evolus Inc

Healthcare · Drug Manufacturers - Specialty & Generic

7.90$ -1.9% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

Evolus Inc (EOLS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 248 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet EOLS
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
168 189 226 234 230 233 213 229 219 226 221 248
92 112 150 158 150 151 132 145 135 143 139 168
39 63 97 94 85 87 68 62 44 54 50 45
39 63 97 94 85 87 68 62 44 54 50 45
30 31 34 43 45 48 47 48 50 55 52 62
18 11 12 13 15 12 10 26 33 27 25 41
21 21 21 21 21 21 21 21 21 21 21 21
47 47 47 46 47 49 49 49 49 48 47 46
187 210 208 214 224 227 220 247 248 249 249 279
49 48 47 54 61 63 56 64 67 75 68 99
1.4 1.4 1.2 1.0 1.6 1.7 2.0 2.4 2.5 2.5 2.6 2.6
12 4.3 11 10 14 9.2 16 23 23 23 20 44
95 120 121 121 121 122 122 145 146 146 156 157
-19 -21 18 19 5.9 5.5 -6.6 -19 -29 -23 -29 -31
-547 -559 -572 -583 -603 -609 -628 -645 -661 -661 -672 -680
57 57 59 63 63 63 64 65 65 64 65 66

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?